Health Canada notified two cannabis businesses on improper product classification. Organigram Holdings Inc (TSX:OGI) (NASDAQ: OGI) and Indiva Limited (OTCPK:NDVAF) (TSXV:NDVA) improperly classified some of those products as "extracts" rather than "edibles" under the Cannabis Regulations.


Organigram stated: “The company remains of the view that the patent pending products are properly classified as cannabis extracts and compliant with the cannabis regulations, and is assessing its options with its legal advisors. At present, the company has paused production of the products in the current packaging format, pending resolution of the matter.” According to Health Canada’s notification, …

Full story available on